Benzinga | Aug 5, 2021 08:38AM EDT

Catalyst Biosciences Q2 EPS $(0.64) Up From $(0.96) YoY, Sales $1.13M Down From $1.66M YoY

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(0.64) per share. This is a 33.33 percent increase over losses of $(0.96) per share from the same period last year. The company reported $1.13 million in sales this quarter. This is a 31.72 percent decrease over sales of $1.66 million the same period last year.